The relationship between UGT1A1 gene & various diseases and prevention strategies

References

• Abumiya M, Takahashi N, Niioka T, Kameoka Y, Fujishima N, Tagawa H, Sawada K, Miura M. 2014. Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia. Drug Metab Pharmacokinet. 29(6):449–454.
   PubMed Web of Science ®Google Scholar
• Alagoz M, Gilbert DC, El-Khamisy S, Chalmers AJ. 2012. DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. Curr Med Chem. 19(23):3874–3885.
   PubMed Web of Science ®Google Scholar
• Allain EP, Rouleau M, Levesque E, Guillemette C. 2020. Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression. Br J Cancer. 122(9):1277–1287.
   PubMed Web of Science ®Google Scholar
• Amandito R, Rohsiswatmo R, Carolina E, Maulida R, Kresnawati W, Malik A. 2019. Profiling of UGT1A1(*)6, UGT1A1(*)60, UGT1A1(*)93, and UGT1A1(*)28 polymorphisms in Indonesian neonates with hyperbilirubinemia using multiplex PCR sequencing. Front Pediatr. 7:328.
   PubMed Web of Science ®Google Scholar
• Anai S, Iwama E, Yoneshima Y, Otsubo K, Tanaka K, Nakanishi Y, Okamoto I. 2018. Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients. Lung Cancer. 126:156–161.
   PubMed Web of Science ®Google Scholar
• Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H. 1995. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndrome. Lancet. 345(8955):958–959.
   PubMed Web of Science ®Google Scholar
• Baandrup L, Hauggaard A, Winberg BH, Holm B. 2011. Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer. Acta Oncol. 50(3):465–467.
   PubMed Web of Science ®Google Scholar
• Bailly C. 2019. Irinotecan: 25 years of cancer treatment. Pharmacol Res. 148:104398.
   PubMed Web of Science ®Google Scholar
• Bajro MH, Josifovski T, Panovski M, Jankulovski N, Nestorovska AK, Matevska N, Petrusevska N, Dimovski AJ. 2012. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer. Cancer Genet. 205(4):163–167.
   PubMed Web of Science ®Google Scholar
• Barateiro A, Chen S, Yueh MF, Fernandes A, Domingues HS, Relvas J, Barbier O, Nguyen N, Tukey RH, Brites D. 2016. Reduced myelination and increased glia reactivity resulting from severe neonatal Hyperbilirubinemia. Mol Pharmacol. 89(1):84–93.
   PubMed Web of Science ®Google Scholar
• Bezerra LS, Santos-Veloso MAO, Bezerra Junior NDS, Fonseca LCD, Sales WLA. 2018. Impacts of cytochrome P450 2D6 (CYP2D6) genetic polymorphism in tamoxifen therapy for breast cancer. Rev Bras Ginecol Obstet. 40(12):794–799.
   PubMedGoogle Scholar
• Błaszczyk B, Lasoń W, Czuczwar SJ. 2015. Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep. 67(3):426–434.
   PubMed Web of Science ®Google Scholar
• Bock KW. 2012. Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochem Pharmacol. 84(8):1000–1006.
   PubMed Web of Science ®Google Scholar
• Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP. 1995. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 333(18):1171–1175.
   PubMed Web of Science ®Google Scholar
• Cavalcante GC, Amador MA, Ribeiro Dos Santos AM, Carvalho DC, Andrade RB, Pereira EE, Fernandes MR, Costa DF, Santos NP, Assumpcao PP, et al. 2017. Analysis of 12 variants in the development of gastric and colorectal cancers. World J Gastroenterol. 23(48):8533–8543.
   PubMed Web of Science ®Google Scholar
• Cecchin E, Russo A, Corona G, Campagnutta E, Martella L, Boiocchi M, Toffoli G. 2004. UGT1A1*28 polymorphism in ovarian cancer patients. Oncol Rep. 12(2):457–462.
   PubMed Web of Science ®Google Scholar
• Chaouch L, Talbi E, Moumni I, Ben Chaabene A, Kalai M, Chaouachi D, Mallouli F, Ghanem A, Abbes S. 2013. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene. Dis Markers. 35(2):67–72.
   PubMed Web of Science ®Google Scholar
• Chen H, Liang L, Xu H, Xu J, Yao L, Li Y, Tan Y, Li X, Huang Q, Yang Z, et al. 2020. Short term exposure to bilirubin induces encephalopathy similar to Alzheimer’s disease in late life. J Alzheimers Dis. 73(1):277–295.
   PubMed Web of Science ®Google Scholar
• Chen CY, Shiesh SC, Tsao HC, Lin XZ. 2000. Human biliary beta-glucuronidase activity before and after relief of bile duct obstruction: is it the major role in the formation of pigment gallstones? J Gastroenterol Hepatol. 15(9):1071–1075.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhu KW, Zhang DY, Yan H, Liu H, Liu YL, Cao S, Zhou G, Zeng H, Chen SP, et al. 2018. Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens. J Transl Med. 16(1):197.
   PubMed Web of Science ®Google Scholar
• Crigler JF, Jr., Najjar VA. 1952. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 10(2):169–180.
   PubMed Web of Science ®Google Scholar
• Das JK, Xiong X, Ren X, Yang JM, Song J. 2019. Heat shock proteins in cancer immunotherapy. J Oncol. 2019:3267207.
   PubMed Web of Science ®Google Scholar
• De Mattia E, Cecchin E, Polesel J, Lupo F, Tiribelli C, Crovatto M, Buonadonna A, Toffoli G. 2017. UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver Int. 37(9):1345–1353.
   PubMed Web of Science ®Google Scholar
• Diaz-Santa J, Rodriguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, et al. 2020. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia. 34(11):2925–2933.
   PubMed Web of Science ®Google Scholar
• Duguay Y, McGrath M, Lepine J, Gagne JF, Hankinson SE, Colditz GA, Hunter DJ, Plante M, Tetu B, Belanger A, et al. 2004. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res. 64(3):1202–1207.
   PubMed Web of Science ®Google Scholar
• Dura P, Salomon J, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH. 2012. High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer geal cancer risk. Int J Oncol. 40(6):1789–1796.
   PubMed Web of Science ®Google Scholar
• Fan S, Liu C, Jiang Y, Gao Y, Chen Y, Fu K, Yao X, Huang M, Bi H. 2019. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice. J Ethnopharmacol. 245:112103.
   PubMed Web of Science ®Google Scholar
• Fevery J, Blanckaert N, Leroy P, Michiels R, Heirwegh KP. 1983. Analysis of bilirubins in biological fluids by extraction and thin-layer chromatography of the intact tetrapyrroles: application to bile of patients with Gilbert's syndrome, hemolysis, or cholelithiasis. Hepatology. 3(2):177–183.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick E, Mtegha M, Dhawan A. 2008. Crigler-Najjar syndrome: therapeutic options and consequences of mutations in the UGT1A1 complex. Expert Rev Endocrinol Metab. 3(6):725–737.
   PubMedGoogle Scholar
• Franchini M, Targher G, Lippi G. 2010. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem. 50:47–63.
   PubMed Web of Science ®Google Scholar
• Fu S, Wu D, Jiang W, Li J, Long J, Jia C, Zhou T. 2019. Molecular biomarkers in drug-induced liver injury: challenges and future perspectives. Front Pharmacol. 10:1667.
   PubMed Web of Science ®Google Scholar
• Fujiwara R, Sumida K, Kutsuno Y, Sakamoto M, Itoh T. 2015. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Drug Metab Pharmacokinet. 30(1):82–88.
   PubMed Web of Science ®Google Scholar
• Gauthier-Landry L, Belanger A, Barbier O. 2015. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. J Steroid Biochem Mol Biol. 145:187–192.
   PubMed Web of Science ®Google Scholar
• Gazzin S, Strazielle N, Tiribelli C, Ghersi-Egea JF. 2012. Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy. Front Pharmacol. 3:89.
   PubMed Web of Science ®Google Scholar
• Guillemette C, Millikan RC, Newman B, Housman DE. 2000. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 60(4):950–956.
   PubMed Web of Science ®Google Scholar
• Hammad S, Othman A, Meyer C, Telfah A, Lambert J, Dewidar B, Werle J, Nwosu ZC, Mahli A, Dormann C, et al. 2018. Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation. Arch Toxicol. 92(8):2549–2561.
   PubMed Web of Science ®Google Scholar
• Hashemiaghdam A, Mroczek M. 2020. Microglia heterogeneity and neurodegeneration: the emerging paradigm of the role of immunity in Alzheimer’s disease. J Neuroimmunol. 341:577185.
   PubMed Web of Science ®Google Scholar
• Henriksen JN, Bottger P, Hermansen CK, Ladefoged SA, Nissen PH, Hamilton-Dutoit S, Fink TL, Donskov F. 2020. Pazopanib-induced liver toxicity in patients with metastatic renal cell carcinoma: effect of UGT1A1 polymorphism on pazopanib dose reduction, safety, and patient outcomes. Clin Genitourin Cancer. 18(1):62–68. e62.
   PubMed Web of Science ®Google Scholar
• Hirose K, Yamashita K, Takada H, Kaneda N, Fukami K, Maruo E, Kitamura M, Hasegawa J, Maeda Y. 2014. Usefulness of one-point plasma SN-38G/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration. Int J Clin Oncol. 19(2):397–402.
   PubMed Web of Science ®Google Scholar
• Huang CS. 2005. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese. J Biomed Sci. 12(3):445–450.
   PubMed Web of Science ®Google Scholar
• Huangfu H, Pan H, Wang B, Wen S, Han R, Li L. 2016. Association between UGT1A1 polymorphism and risk of laryngeal squamous cell carcinoma. Int J Environ Res Public Health. 13(1):112.
   PubMed Web of Science ®Google Scholar
• Huo D, Kim HJ, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Niu Q, Sveen L, Fackenthal JD, et al. 2008. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans. Breast Cancer Res Treat. 110(2):367–376.
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Arai Y, Maeta Y, Ashida K, Katano K, Wakatsuki T. 2011. Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer. Surg Today. 41(9):1196–1199.
   PubMed Web of Science ®Google Scholar
• Iyanagi T. 2007. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int Rev Cytol. 260:35–112.
   PubMed Web of Science ®Google Scholar
• Justenhoven C, Winter S, Dunnebier T, Hamann U, Baisch C, Rabstein S, Spickenheuer A, Harth V, Pesch B, Bruning T, et al. 2010. Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk. Breast Cancer Res Treat. 124(1):289–292.
   PubMed Web of Science ®Google Scholar
• Kamal S, Abdelhakam S, Ghoraba D, Massoud Y, Aziz KA, Hassan H, Hafez T, Abdel Sallam A. 2019. The frequency, clinical course, and health related quality of life in adults with Gilbert’s syndrome: a longitudinal study. BMC Gastroenterol. 19(1):22.
   PubMed Web of Science ®Google Scholar
• Kang LL, Ma YJ, Zhang HD. 2020. Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome. Medicine. 99(7):e19109.
   PubMed Web of Science ®Google Scholar
• Karakosta M, Kalotychou V, Kostakis A, Pantelias G, Rombos I, Kouraklis G, Manola KN. 2014. UGT1A1*28 polymorphism in chronic lymphocytic leukemia: the first investigation of the polymorphism in disease susceptibility and its specific cytogenetic abnormalities. Acta Haematol. 132(1):59–67.
   PubMed Web of Science ®Google Scholar
• Karimzadeh P, Fallahi M, Kazemian M, Taslimi Taleghani N, Nouripour S, Radfar M. 2020. Bilirubin induced encephalopathy. Iran J Child Neurol. 14(1):7–19.
   PubMed Web of Science ®Google Scholar
• Kawashita Y, Soutome S, Umeda M, Saito T. 2020. Oral management strategies for radiotherapy of head and neck cancer. Jpn Dent Sci Rev. 56(1):62–67.
   PubMed Web of Science ®Google Scholar
• Kimura T, Akaba K, Ikegami T, Akiba K, Kanazawa C, Katsuura M, Shimizu Y, Imaizumi M, Lin C, Hayasaka K. 1999. Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians. J Inherit Metab Dis. 22(6):747–753.
   PubMed Web of Science ®Google Scholar
• Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamlya N, Sato H. 1995. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mole Genet. 4(7):1183–1186.
   PubMed Web of Science ®Google Scholar
• Korprasertthaworn P, Chau N, Nair PC, Rowland A, Miners JO. 2019. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202. Biochem Pharmacol. 169:113616.
   PubMed Web of Science ®Google Scholar
• Kundu R, Dasgupta S, Biswas A, Bhattacharya S, Pal BC, Bhattacharya S, Rao PG, Barua NC, Bordoloi M, Bhattacharya S. 2011. Carlinoside reduces hepatic bilirubin accumulation by stimulating bilirubin-UGT activity through Nrf2 gene expression. Biochem Pharmacol. 82(9):1186–1197.
   PubMed Web of Science ®Google Scholar
• Kuo SH, Yang SY, You SL, Lien HC, Lin CH, Lin PH, Huang CS. 2017. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer. Oncotarget. 8(13):20925–20938.
   PubMedGoogle Scholar
• Lacko M, Roelofs HM, Te Morsche RH, Voogd AC, Ophuis MB, Peters WH, Manni JJ. 2010. Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer. Int J Cancer. 127(12):2815–2821.
   PubMed Web of Science ®Google Scholar
• Landmann H, Proia DA, He S, Ogawa LS, Kramer F, Beißbarth T, Grade M, Gaedcke J, Ghadimi M, Moll U, et al. 2014. UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib. Cell Death Dis. 5:e1411.
   PubMed Web of Science ®Google Scholar
• Lenicek M, Duricova D, Hradsky O, Dusatkova P, Jiraskova A, Lukas M, Nachtigal P, Vitek L. 2014. The relationship between serum bilirubin and Crohn’s disease. Inflamm Bowel Dis. 20(3):481–487.
   PubMed Web of Science ®Google Scholar
• Li T, Xu L, Zheng R, Wang X, Li L, Ji H, Hu Q. 2020. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Phytomedicine. 68:153153.
   PubMed Web of Science ®Google Scholar
• Li X, Yang J, Jin S, Dai Y, Fan Y, Fan X, Li Z, Yang J, Yau WP, Lin H, et al. 2020. Mechanistic examination of methimazole-induced hepatotoxicity in patients with Grave’s disease: a metabolomic approach. Arch Toxicol. 94(1):231–244.
   PubMed Web of Science ®Google Scholar
• Lin FC, Hsu CH, Lin YY. 2018. Nano-therapeutic cancer immunotherapy using hyperthermia-induced heat shock proteins: insights from mathematical modeling. Int J Nanomedicine. 13:3529–3539.
   PubMed Web of Science ®Google Scholar
• Liu G, Ruan G, Huang M, Chen L, Sun P. 2020. Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities. Aging (Albany NY). 12(1):178–192.
   PubMedGoogle Scholar
• Liu XQ, Tufman A, Kiefl R, Li GF, Ma QL, Huber RM. 2020. Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysis. Eur Rev Med Pharmacol Sci. 24(4):1877–1886.
   PubMed Web of Science ®Google Scholar
• Liu D, Yu Q, Li Z, Zhang L, Hu M, Wang C, Liu Z. 2021. UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder. Biochem Pharmacol. 190:114592.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang L, Duan LX, Wu JJ, Hu M, Liu ZQ, Wang CY. 2019. Potential of herb-drug/herb interactions between substrates and inhibitors of UGTs derived from herbal medicines. Pharmacol Res. 150:104510.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang G, Song M, Wang J, Shen C, Chen Z, Huang X, Gao Y, Zhu C, Lin C, et al. 2020. Activation of farnesoid X receptor by schaftoside ameliorates acetaminophen-induced hepatotoxicity by modulating oxidative stress and inflammation. Antioxid Redox Signal. 33(2):87–116.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhou J, Shi J, Peng XJ, Qi XX, Wang Y, Li FY, Zhou FY, Liu L, Liu ZQ. 2015. Drug-metabolizing activity, protein and gene expression of UDP-glucuronosyltransferases are significantly altered in hepatocellular carcinoma patients. PLoS One. 10(5):e0127524.
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, MacDonald IJ, Arnouk H, Yang GY, Pritchard MT, Subjeck JR. 2004. Cancer immunotherapy and heat-shock proteins: promises and challenges. Expert Opin Biol Ther. 4(3):363–373.
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, Park J, Facciponte JG, Repasky EA, Subjeck JR. 2002. Immunotherapy of cancer using heat shock proteins. Front Biosci. 7:d43–52.
   PubMed Web of Science ®Google Scholar
• Mano ECC, Scott AL, Honorio KM. 2018. UDP-glucuronosyltransferases: structure, function and drug design studies. Curr Med Chem. 25(27):3247–3255.
   PubMed Web of Science ®Google Scholar
• Marques D, Ferreira-Costa LR, Ferreira-Costa LL, Correa RDS, Borges AMP, Ito FR, Ramos CCO, Bortolin RH, Luchessi AD, Ribeiro-Dos-Santos A, et al. 2017. Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features. World J Gastroenterol. 23(37):6854–6867.
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30(9):2174–2187.
   PubMed Web of Science ®Google Scholar
• Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI. 2019. The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms. Physiol Rev. 99(2):1153–1222.
   PubMed Web of Science ®Google Scholar
• Mi XX, Yan J, Ma XJ, Zhu GL, Gao YD, Yang WJ, Kong XW, Chen GY, Shi JP, Gong L. 2019. Analysis of the UGT1A1 genotype in hyperbilirubinemia patients: differences in allele frequency and distribution. Biomed Res Int. 2019:6272174.
   PubMed Web of Science ®Google Scholar
• Mitsugi R, Sumida K, Fujie Y, Tukey RH, Itoh T, Fujiwara R. 2016. Acyl-glucuronide as a possible cause of trovafloxacin-induced liver toxicity: induction of chemokine (C-X-C motif) ligand 2 by trovafloxacin acyl-glucuronide. Biol Pharm Bull. 39(10):1604–1610.
   PubMed Web of Science ®Google Scholar
• Negoro Y, Yano R, Yoshimura M, Suehiro Y, Yamashita S, Kodawara T, Watanabe K, Tsukamoto H, Nakamura T, Kadowaki M, et al. 2019. Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer. Int J Clin Oncol. 24(3):256–261.
   PubMed Web of Science ®Google Scholar
• Ning C, Gao X, Wang C, Kong Y, Liu Z, Sun H, Sun P, Huo X, Ma X, Meng Q, et al. 2018. Ginsenoside Rg1 protects against acetaminophen-induced liver injury via activating Nrf2 signaling pathway in vivo and in vitro. Regul Toxicol Pharmacol. 98:58–68.
   PubMed Web of Science ®Google Scholar
• Nizam MA, Alvi AS, Hamdani MM, Lalani AS, Sibtain SA, Bhangar NA. 2020. Efficacy of double versus single phototherapy in treatment of neonatal jaundice: a meta-analysis. Eur J Pediatr. 179(6):865–874.
   PubMed Web of Science ®Google Scholar
• Nomura A, Maruo Y, Taga T, Takeuchi Y. 2016. Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients. Pediatr Res. 80(2):252–257.
   PubMed Web of Science ®Google Scholar
• Olatunya OS, Albuquerque DM, Akanbi GO, Aduayi OS, Taiwo AB, Faboya OA, Kayode TS, Leonardo DP, Adekile A, Costa FF. 2019. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria. BMC Med Genet. 20(1):160.
   PubMed Web of Science ®Google Scholar
• Panagopoulos P, Paraskevis D, Katsarolis I, Sypsa V, Detsika M, Protopapas K, Antoniadou A, Papadopoulos A, Petrikkos G, Hatzakis A. 2014. High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece. Int J STD Aids. 25(12):860–865.
   PubMed Web of Science ®Google Scholar
• Papageorgiou I, Freytsis M, Court MH. 2016. Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver. Biochem Pharmacol. 117:78–87.
   PubMed Web of Science ®Google Scholar
• Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, et al. 2012. Estrogen-related genes and their contribution to racial differences in breast cancer risk. Cancer Causes Control. 23(5):671–681.
   PubMed Web of Science ®Google Scholar
• Ren W, Zhou C, Liu Y, Su K, Jia L, Chen L, Li M, Ma J, Zhou W, Zhang S, et al. 2020. Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population. J Clin Pharm Ther. 45(2):354–364.
   PubMed Web of Science ®Google Scholar
• Rougee LR, Miyagi SJ, Collier AC. 2016. Obstetric obesity is associated with neonatal hyperbilirubinemia with high prevalence in native Hawaiians and pacific Island women. Hawai'i J Med Public Health. 75(12):373–378.
   PubMedGoogle Scholar
• Shatalova EG, Loginov VI, Braga EA, Kazubskaia TP, Sudomoina MA, Blanchard RL, Favorova OO. 2006. Association of polymorphisms in SULT1A1 and UGT1A1 genes with breast cancer risk and phenotypes in Russian women. Mol Biol (Mosk)). 40(2):263–270.
   PubMed Web of Science ®Google Scholar
• Shatalova EG, Walther SE, Favorova OO, Rebbeck TR, Blanchard RL. 2005. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study. Breast Cancer Res. 7(6):R909–921.
   PubMed Web of Science ®Google Scholar
• Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, et al. 2019. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology. 156(8):2230–2241 e2211.
   PubMed Web of Science ®Google Scholar
• Shi J, Li LH, Duan XY, Liu Q, Sun LL, Tian YT. 2016. Gly71Arg UGT1A1 polymorphism is associated with breast cancer susceptibility in Han Chinese women. Genet Mol Res. 15(3):15038332.
   Web of Science ®Google Scholar
• Shi B, Su Y, Chang S, Sun Y, Meng X, Shan A. 2017. Vitamin C protects piglet liver against zearalenone-induced oxidative stress by modulating expression of nuclear receptors PXR and CAR and their target genes. Food Funct. 8(10):3675–3687.
   PubMed Web of Science ®Google Scholar
• Shibuya A, Itoh T, Tukey RH, Fujiwara R. 2013. Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia. Sci Rep. 3:2903.
   PubMed Web of Science ®Google Scholar
• Si J, Zhao X, Gao S, Huang D, Sui M. 2019. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin. Int J Pharm. 568:118499.
   PubMed Web of Science ®Google Scholar
• Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. 2018. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: a case report. World J Clin Cases. 6(16):1206–1209.
   PubMed Web of Science ®Google Scholar
• Starlard-Davenport A, Word BR, Lyn-Cook B. 2012. Characterization of UDP-glucuronosyltransferase (UGT1A1) promoter polymorphisms and gene expression on ethnicity, stage of disease, and menopausal status in breast cancer. J Drug Metab Toxicol. 2012(Suppl 4):https://doi.org/10.4172/2157-7609.S4-001. DOI:https://doi.org/10.4172/2157-7609.S4-001.
   PubMedGoogle Scholar
• Strassburg CP. 2008. Pharmacogenetics of Gilbert’s syndrome. Pharmacogenomics. 9(6):703–715.
   PubMed Web of Science ®Google Scholar
• Strassburg CP. 2010. Gilbert-Meulengracht’s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev. 42(1):168–181.
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Manns MP, Tukey RH. 1997. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res. 57(14):2979–2985.
   PubMed Web of Science ®Google Scholar
• Sukasem C, Sririttha S, Tempark T, Klaewsongkram J, Rerkpattanapipat T, Puangpetch A, Boongird A, Chulavatnatol S. 2020. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population. Pharmacoepidemiol Drug Saf. 29(5):565–574.
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu HP, Zheng RJ, Wang P, Liu ZB, Sha W, Xiao HP. 2017. Genetic polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and susceptibility to anti-tuberculosis drug-induced hepatotoxicity: a Chinese population-based prospective case-control study. Clin Drug Investig. 37(12):1125–1136.
   PubMed Web of Science ®Google Scholar
• Sung KC, Shin J, Lim YH, Wild SH, Byrne CD. 2013. Relation of conjugated bilirubin concentrations to the presence of coronary artery calcium. Am J Cardiol. 112(12):1873–1879.
   PubMed Web of Science ®Google Scholar
• Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, et al. 2011. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 32(10):1500–1506.
   PubMed Web of Science ®Google Scholar
• Teh LK, Hashim H, Zakaria ZA, Salleh MZ. 2012. Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia. Indian J Med Res. 136(2):249–259.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Zhao W, Yang X, Zhong DN. 2020. The relationship between hyperbilirubinemia and the promoter region and first exon of UGT1A1 gene polymorphisms in Vietnamese newborns. Pediatr Res. 88(6):940–944.
   PubMed Web of Science ®Google Scholar
• Tsai MS, Wang YH, Lai YY, Tsou HK, Liou GG, Ko JL, Wang SH. 2018. Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice. Toxicol Lett. 290:97–109.
   PubMed Web of Science ®Google Scholar
• Verma H, Singh Bahia M, Choudhary S, Kumar Singh P, Silakari O. 2019. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it. Drug Metab Rev. 51(2):196–223.
   PubMed Web of Science ®Google Scholar
• Vitek L, Ostrow JD. 2009. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des. 15(25):2869–2883.
   PubMed Web of Science ®Google Scholar
• Williamson SC, Mitter R, Hepburn AC, Wilson L, Mantilla A, Leung HY, Robson CN, Heer R. 2013. Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer. Br J Cancer. 109(4):950–956.
   PubMed Web of Science ®Google Scholar
• Xie ZC, Li TT, Gan BL, Gao X, Gao L, Chen G, Hu XH. 2018. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Pathol Res Pract. 214(5):644–654.
   PubMed Web of Science ®Google Scholar
• Xie H, Sun S, Cheng X, Yan T, Zheng X, Li F, Qi Q, Wang G, Hao H. 2013. Dysregulations of intestinal and colonic UDP-glucuronosyltransferases in rats with type 2 diabetes. Drug Metab Pharmacokinet. 28(5):427–434.
   PubMed Web of Science ®Google Scholar
• Yan T, Gao S, Peng X, Shi J, Xie C, Li Q, Lu L, Wang Y, Zhou F, Liu Z, et al. 2015. Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method. Pharm Res. 32(3):1141–1157.
   PubMed Web of Science ®Google Scholar
• Yong M, Schwartz SM, Atkinson C, Makar KW, Thomas SS, Newton KM, Aiello Bowles EJ, Holt VL, Leisenring WM, Lampe JW. 2010. Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. Cancer Epidemiol Biomarkers Prev. 19(2):537–546.
   PubMed Web of Science ®Google Scholar
• Yueh MF, Chen S, Nguyen N, Tukey RH. 2017. Developmental, genetic, dietary, and xenobiotic influences on neonatal hyperbilirubinemia. Mol Pharmacol. 91(5):545–553.
   PubMed Web of Science ®Google Scholar
• Zeidan AM, Podoltsev NA, Wang X, Zhang C, Bewersdorf JP, Shallis RM, Huntington SF, Neparidze N, Giri S, Gore SD, et al. 2020. Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States. Blood Adv. 4(8):1615–1623.
   PubMed Web of Science ®Google Scholar
• Zeng H, Jiang Y, Chen P, Fan X, Li D, Liu A, Ma X, Xie W, Liu P, Gonzalez FJ, et al. 2017. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br J Pharmacol. 174(8):672–688.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chu X, Wang H, Xie H, Guo C, Cao L, Zhou X, Wang G, Hao H. 2013. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver. Eur J Pharmacol. 721(1–3):277–285.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang Y, Yuan F, Song C, Zhao Z, Jiang W. 2020. An epileptic patient with recurrent hyperbilirubinemia caused by gilbert syndrome. Case Rep Gastroenterol. 14(1):39–47.
   PubMedGoogle Scholar
• Zhang L, Xu P, Cheng Y, Wang P, Ma X, Liu M, Wang X, Xu F. 2019. Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats. Biochem Pharmacol. 164:368–376.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li L, Li X, Li J, Wang D, Zhang H. 2019. The relationship between serum bilirubin and inflammatory bowel disease. Mediators Inflamm. 2019:5256460.
   PubMed Web of Science ®Google Scholar